<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Journal of Volgograd State Medical University</journal-id><journal-title-group><journal-title xml:lang="en">Journal of Volgograd State Medical University</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Волгоградского государственного медицинского университета</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1994-9480</issn><issn publication-format="electronic">1994-9499</issn><publisher><publisher-name xml:lang="en">Volgograd State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">118345</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">OPTIMIZATION OF THE STRUCTURE OF METHYLATED 1-(BENZYLOXYMETHYL)-5-(ARYLAMINO) URACIL DERIVATIVES WITH ANTI-HIV-1 ACTIVITY</article-title><trans-title-group xml:lang="ru"><trans-title>ОПТИМИЗАЦИЯ СТРУКТУРЫ МЕТИЛИРОВАННЫХ ПРОИЗВОДНЫХ 1-(БЕНЗИЛОКСИМЕТИЛ)-5-(АРИЛАМИНО)-УРАЦИЛА, ОБЛАДАЮЩИХ АНТИ-ВИЧ-1 АКТИВНОСТЬЮ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lobachev</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Лобачев</surname><given-names>А. А.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ozerov</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Озеров</surname><given-names>Александр Александрович</given-names></name></name-alternatives><bio xml:lang="ru"><p>д. х. н., профессор, зав. кафедрой фармацевтической и токсикологической химии</p></bio><email>prof_ozerov@yahoo.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Novikov</surname><given-names>M. S.</given-names></name><name xml:lang="ru"><surname>Новиков</surname><given-names>М. С.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Luganchenko</surname><given-names>A. I.</given-names></name><name xml:lang="ru"><surname>Луганченко</surname><given-names>А. И.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Hartman</surname><given-names>T.</given-names></name><name xml:lang="ru"><surname>Хартман</surname><given-names>Т.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>W Buckheit</surname><given-names>R. U.</given-names></name><name xml:lang="ru"><surname>Букхайт</surname><given-names>Р. У.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">Волгоградский государственный медицинский университет</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">Научно-исследовательский институт фармакологии, ImQuestBioScience Inc.</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2012-01-15" publication-format="electronic"><day>15</day><month>01</month><year>2012</year></pub-date><volume>9</volume><issue>1</issue><issue-title xml:lang="en">NO1 (2012)</issue-title><issue-title xml:lang="ru">№1 (2012)</issue-title><fpage>91</fpage><lpage>93</lpage><history><date date-type="received" iso-8601-date="2022-12-16"><day>16</day><month>12</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2012, Lobachev A.A., Ozerov A.A., Novikov M.S., Luganchenko A.I., Hartman T., W Buckheit R.U.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2012, Лобачев А.А., Озеров А.А., Новиков М.С., Луганченко А.И., Хартман Т., Букхайт Р.У.</copyright-statement><copyright-year>2012</copyright-year><copyright-holder xml:lang="en">Lobachev A.A., Ozerov A.A., Novikov M.S., Luganchenko A.I., Hartman T., W Buckheit R.U.</copyright-holder><copyright-holder xml:lang="ru">Лобачев А.А., Озеров А.А., Новиков М.С., Луганченко А.И., Хартман Т., Букхайт Р.У.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.eco-vector.com/1994-9480/article/view/118345">https://journals.eco-vector.com/1994-9480/article/view/118345</self-uri><abstract xml:lang="en"><p>New substituted derivatives of 1-(benzyloxymethyl)-5-(arylamino)uracil were synthesized by trimethylsilyl modification of Gilbert-Johnson method. The level of anti-HIV-1 activity of methylated 5-(benzylamino) derivatives depends on the site of methylation: 3,5-dimethylbenzylamino derivatives were found to be more active than corresponding α- or N-methylated isomers.</p></abstract><trans-abstract xml:lang="ru"><p>Триметилсилильной модификацией метода Гилберта-Джонсона синтезированы новые замещенные производные 1-(бензилоксиметил)-5-(ариламино)урацила. Обнаружено, что уровень анти-ВИЧ-1 активности метилированных 5-(бензиламино)производных зависит от положения метильной группы: 3,5-диметилбензиламинопроизводное оказалось значительно активнее, чем соответствующие α- или N-метилированные изомеры.</p></trans-abstract><kwd-group xml:lang="en"><kwd>antiviral activity</kwd><kwd>HIV-1</kwd><kwd>uracil</kwd><kwd>pyrimidine</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>противовирусная активность</kwd><kwd>ВИЧ-1</kwd><kwd>урацил</kwd><kwd>пиримидин</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Новиков М. С., Озеров А. А., Тимофеева К. В., Солодунова Г. Н. // Современные проблемы науки и образования. - 2008. - Вып. 1. - С. 29-30.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Озеров А. А., Новиков М. С., Гнатюк В. П. и др. // Бюллетень Волгоградского научного центра РАМН. -2004. - Вып. 1. - С. 26-28.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Novikov M. S., Ivanova O. N., Ivanov A. V., et al. // Bioorg. Med. Chem. - 2011. - Vol. 19. - P 5794-5902.</mixed-citation></ref></ref-list></back></article>
